MTOR and renal cell carcinoma: The PI3K-AKT-mTOR signaling pathway is frequently upregulated in RCC due to mechanisms that include PTEN mutation/depletion, PI3KCA mutation, and sustained activation of receptor tyrosine kinases (RTKs)2–5.